Alnylam Pharmaceuticals (ALNY) PT Lowered to $211 at BofA Securities
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $255.96 +2.55%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $211.00 (from $227.00) while maintaining a Buy rating.
- 'CEO exit a surprise but fundamentals seem intact'
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AMD (AMD) PT Raised to $720 at BofA Securities
- Freedom Broker Starts Autoliv, Inc. (ALV) at Buy
- Akamai Technologies (AKAM) PT Raised to $149 at TD Cowen
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
